Category: Biotechnology
Biotechnology market research reports by Plunkett Research, Ltd.
-
Puma Biotechnology Inc (PBYI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Puma Biotechnology Inc (PBYI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Puma Biotechnology Inc (PBYI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findi ... Read More
-
Agilent Technologies Inc (A:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Agilent Technologies Inc (A:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Agilent Technologies Inc (A:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Finding ... Read More
-
4D Molecular Therapeutics Inc (FDMT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
4D Molecular Therapeutics Inc (FDMT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry 4D Molecular Therapeutics Inc (FDMT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Indus ... Read More
-
Histogen Inc (HSTO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Histogen Inc (HSTO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Histogen Inc (HSTO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new ... Read More
-
Anika Therapeutics Inc (ANIK:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Anika Therapeutics Inc (ANIK:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Anika Therapeutics Inc (ANIK:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findi ... Read More
-
Aceragen Inc (ACGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Aceragen Inc (ACGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Aceragen Inc (ACGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new ... Read More
-
Myriad Genetics Inc (MYGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Myriad Genetics Inc (MYGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Myriad Genetics Inc (MYGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. T ... Read More
-
Geron Corporation (GERN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Geron Corporation (GERN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Geron Corporation (GERN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This ... Read More
-
Matinas BioPharma Hldgs Inc (MTNB:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Matinas BioPharma Hldgs Inc (MTNB:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Matinas BioPharma Hldgs Inc (MTNB:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. ... Read More
-
Albireo Pharma Inc (ALBO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Albireo Pharma Inc (ALBO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Albireo Pharma Inc (ALBO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. Thi ... Read More
-
Natera Inc (NTRA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Natera Inc (NTRA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Natera Inc (NTRA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new rep ... Read More
-
Fate Therapeutics Inc (FATE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Fate Therapeutics Inc (FATE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Fate Therapeutics Inc (FATE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Finding ... Read More
-
Nektar Therapeutics (NKTR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Nektar Therapeutics (NKTR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Nektar Therapeutics (NKTR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. T ... Read More
-
Amgen Inc (AMGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Amgen Inc (AMGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Amgen Inc (AMGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new repor ... Read More
-
Regen BioPharma Inc (RGBP:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Regen BioPharma Inc (RGBP:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Regen BioPharma Inc (RGBP:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. ... Read More
-
ADMA Biologics Inc (ADMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
ADMA Biologics Inc (ADMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry ADMA Biologics Inc (ADMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. Thi ... Read More
-
United Therapeutics Corporation (UTHR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
United Therapeutics Corporation (UTHR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry United Therapeutics Corporation (UTHR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its I ... Read More
-
Cerus Corporation (CERS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Cerus Corporation (CERS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Cerus Corporation (CERS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This ... Read More
-
Gilead Sciences Inc (GILD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Gilead Sciences Inc (GILD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Gilead Sciences Inc (GILD:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. T ... Read More
-
US Stem Cell Inc (USRM:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
US Stem Cell Inc (USRM:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry US Stem Cell Inc (USRM:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This ... Read More
-
Plunkett's Health Care Industry Almanac 2024: Health Care Industry Market Research, Statistics, Trends and Leading Companies
PLUNKETT'S HEALTH CARE INDUSTRY ALMANAC 2024 Key Findings: A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Health Care Industry. Gain vital insights that can help shape strategy for business developme ... Read More
-
Scientific Research and Development (R&D) in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 541710
Scientific Research and Development (R&D) in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmarks Against Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 541710 Vital ... Read More
-
Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2024: Biotech, Pharmaceuticals & Genetics Industry Market Research, Statistics, Trends and Leading Companies
PLUNKETT'S BIOTECH, PHARMACEUTICALS & GENETICS INDUSTRY ALMANAC 2024 Key Findings: A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Biotech, Pharmaceuticals & Genetics Industry. Gain vital insights tha ... Read More
-
Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2027, NAIC 541711
Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmarks Against Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 541711 Vital industry ... Read More
-
Foghorn Therapeutics Inc (FHTX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Foghorn Therapeutics Inc (FHTX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Foghorn Therapeutics Inc (FHTX:NAS) compared to its top competitors and compared t ... Read More
Research Assistance
